since few weeks holidays are over, and the autumn- conference- postpandemic-vortex is keeping us moving!
BioRN as well...
... we are finalising last details in the Halle02 to welcome you to BioRN Annual Conference. This is the very last call for registration!
This week we hosted together with BioLabs Heidelberg a CoffeeTalk with AbbVie. AbbVie top-management had also the chance to visit BioLabs Heidelberg future home.
On October 10, we organise together with BioLabs Heidelberg, Heidelberg Startup Partners and Life Science Accelerator Baden-Württemberg, the Life Science Investors’ Day in Heidelberg, to facilitate a continuous exchange between investors and founders.
A day after, on October 11, Merck is visiting this dynamic ecosystem and launching the Golden Ticket Challenge for BioLabs Heidelberg in a Merck BioLabs day. The BioRN Lounge on October 25 closes the month.
Under the words 'internationalisation' and 'personalised medicine' we have a delegation visiting the Leuven Ecosystem in Belgium on October 20-21 and one from Canada coming to Heidelberg on October 20. If you want to join us contact me!
Check out the many new members and see you next Friday for the Annual Conference!
Annalisa Zuccotti
Events & Communication Lead
BioRN Life Science Cluster Rhine-Neckar
01 | Research Highlights & News
02 | New BioRN Members
03 | BioRN Events
04 | Event Calendar & Discounts
05 | Open Positions
01| Research Highlights & News
Ascendis Pharma: Submits New Drug Application to FDA for Adult Patients with Hypoparathyroidism [more]
BioLabs announces strategic partnership with Novo Nordisk in Europe [more]
BioMed X and Merck Start New Research Project in Oncology [more]
DKFZ: Breaking down proteins: How starving cancer cells switch food sources [more]
faCellitate a BASF spin-off, raises 3.7 million euros in first financing round [more]
HEALTH + LIFE SCIENCE ALLIANCE HEIDELBERG MANNHEIM Inaugural Event [more]
Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda [more]
NCT, Heidelberg University Hospital, DKFZ: How do glioblastoma invade and colonize the entire brain? Scientists uncover three mechanisms [more]
Medical infrastructure in expansion:
extension for the pharmacy of Heidelberg University Hospital [more]
groundbreacking of the Hopp-Kindertumorzentrums Heidelberg (KiTZ) [more]
Decentralized elements such as wearables, telemedicine or ePRO are increasingly used in clinical trials. Patient recruitment is also taking place via digital channels more and more. But how successfully are these tools actually used and where do sponsors and sites see the greatest potential? Complete this survey to help Trialflow and partners draw a picture of the future of clinical trials! >>
02 | New BioRN Members
Easily find and connect with the world's scientific experts and rising stars to collaborate, consult, monitor, license a technology, sell, or recruit.
AcademicLabs.com is the first user-friendly and comprehensive interface that brings together the world's scientific research, experts, biotech startups and pharmaceutical companies - all in one place!
Deep LS helps (bio)pharmaceutical companies to accelerate their drug discovery process. With this AI Technology de novo ligand design solution, the customers are empowered to control the chemical space. They can generate small molecules and proteins that fit to their target and meet additional criteria, e.g. toxicity.
DIVERSA is a biotechnology company promoting the transfer to the clinic of new therapeutic molecules through the application of drug delivery nanotechnology. DIVERSA wants to build a bridge between molecules and patients, between drug discovery and clinical application. DIVERSA aspires to become the company of reference for drug delivery, opening new opportunities for innovative medicines and improving patients’ lives.
Forever Healthy is a non-profit humanitarian initiative with the mission of enabling people to vastly extend their healthy lifespan. Forever Healthy’s projects include the evaluation of new rejuvenation therapies, evidence-based curation of the world’s cutting-edge medical knowledge, funding translational research on the root causes of ageing, and hosting topic-specific events.
Value Data converts data into value - for companies and for society. Digital technologies create advances and integrate an understanding of data as part of every business strategy and processes. ValueData GmbH uses machine learning and deep learning of driven systems to integrate intelligence into customers´products and solutions under the aspects of modern software development methods and the continuous delivery concept as well a in the sense of social responsibility.
03 | BioRN Events
04 | Event Calendar & Discounts
PEPcademy Workshop Series Heidelberg Learn from different experts how you can apply PEPperCHIP® Peptide Microarrays in your research
October 21, 2022 - Heidelberg >>
„StartupTrifftMittelstand“ October 11, 2022 - on-line >>
Road to the Clinic for Small Molecules October 18, 2022 - Leiden & Online >>
Engineering human neurons: Building preclinical models to study treatments for mental disorders Lunch Talk series
October 20, 2022, Heidelberg >>
BIO-Europe October 24-26, 2022 - Leipzig
10% off for members >>
Bayesian Clinical Trials Theoretical foundation and hands-on application of Bayesian statistics in clinical trials
October 27-28, 2022 - Heidelberg >>
BioTechX November 8-10, 2022 - Basel
50% Discount for BioRN members >>
Festival of Biologics November 2-4, 2022 - Basel
10% Discount for BioRN members >>
Investor Perspective: The Strategic Venturing Spectrum November 10, 2022 - Leiden & Online >>
Computer-Augmented Molecular Design Enabling Biotech Companies to Accelerate the Drug Discovery Process November 22, 2022 - Heidelberg >>
The Spectra Of Life: Dimensional Breadth In Biological Research EMBL PhD Symposium
December 7-9, 2022 - Heidelberg >>
BioFIT Event Discount for BioRN Members
November 29-30,2022 - Strasbourg, France >>
05 | Open Positions
Apogenix: Office Manger (m/w/d) in Heidelberg[more]
DKFZ: Manager for Business Development and Transition Planning[more]
You are currently viewing a placeholder content from Mailchimp. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
